Volume 30, Number 5—May 2024
Synopsis
Coccidioidomycosis-Related Hospital Visits, Texas, USA, 2016–2021
, Vanora Davila, and Elena Penedo
Table 4
Patient demographics and prevalence ratios for coccidioidomycosis-related hospital visits, Texas, USA, 2016–2021*
| Demographics | PR (95% CI) | p value |
|---|---|---|
| Patient sex | ||
| F | Referent | NA |
| M |
2.81 (2.43–3.25) |
<0.01 |
| Race/ethnicity | ||
| Non-Hispanic White | Referent | NA |
| Non-Hispanic Black | 1.51 (1.24–1.84) | <0.01 |
| Non-Hispanic other† | 0.97 (0.78–1.19) | 0.74 |
| Hispanic |
1.25 (1.05–1.48) |
0.01 |
| Geographic region | ||
| Non–Valley fever region | Referent | NA |
| Valley fever region‡ | 5.79 (5.03–6.66) | <0.01 |
*International Classification of Diseases, 10th Revision, Clinical Modification, codes were used to determine a coccidioidomycosis diagnosis and included codes B38, B38.0, B38.1, B38.2, B38.3, B38.4, B38.7, B38.8, B38.81, B38.89, B38.9. p values <0.01 were considered significant. NA, not applicable; PR, prevalence ratio. †Non-Hispanic other category also includes American Indian/Eskimo/Aleut, Asian or Pacific Islander, and other. If a hospital has <10 patients of 1 race, that race is changed to other, and the ethnicity of patients of that race is suppressed. ‡The 96-county area of Texas estimated to be coccidioidomycosis-endemic was determined by using Centers for Disease Control and Prevention Valley fever maps spatially overlaid on a Texas county map. Any county that fell within the estimated area was designated as a Valley fever region.